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Although mass-spectrometry-based screens enable
thousands of protein phosphorylation sites to be
monitored simultaneously, they often do not cover
important regulatory sites. Here, we hypothesized
that this is due to the fact that nearly all large-scale
phosphoproteome studies are initiated by trypsin
digestion. We tested this hypothesis using multiple
proteases for protein digestion prior to Ti4+-IMAC-
based enrichment. This approach increases the
size of the detectable phosphoproteome substan-
tially and confirms the considerable tryptic bias in
public repositories. We define and make available a
less biased human phosphopeptide atlas of 37,771
unique phosphopeptides, correlating to 18,430 uni-
que phosphosites, of which fewer than 1/3 were
identified in more than one protease data set. We
demonstrate that each protein phosphorylation site
can be linked to a preferred protease, enhancing its
detection by mass spectrometry (MS). For specific
sites, this approach increases their detectability by
more than 1,000-fold.INTRODUCTION
Cellular signaling proceeds largely via cascades of post-transla-
tional modifications, in which reversible protein phosphorylation
provides a key mechanism (Huang and White, 2008; Rigbolt and
Blagoev, 2012). Site-specific protein phosphorylation can be
monitored by site-specific phospho-antibodies, such as those
raised against, for instance, pERK T202/Y204 and pSRC Y419.
Although powerful, there are only a limited number of these
antibodies available, hardly sufficient to monitor the more than
100,000 unique phosphosites present in a human cell. Other
caveats in using these antibodies are their limited specificity,
recognizing multiple sites in a single protein, or similar phos-
pho-sequences in other proteins. Moreover, these approaches
are difficult to multiplex for use in high-throughput assays.1834 Cell Reports 11, 1834–1843, June 23, 2015 ª2015 The AuthorsMass spectrometry (MS)-based phosphoproteomics has re-
cently surfaced as the method of choice for global and high-
throughput protein analysis. Immense progress in both mass
spectrometric instrumentation (Hebert et al., 2014; Michalski
et al., 2011, 2012) and sample preparation and analysis (Di
Palma et al., 2012; Ruprecht and Lemeer, 2014; Wisniewski
et al., 2009; Yates et al., 2014) have allowed this technology
to confidently identify as many as thousands of proteins and
phosphorylation sites in a single experiment and to accurately
quantify changes in protein expression or post-translational
modifications (PTMs). Recently, we demonstrated the high po-
tential of a new material for phosphopeptide enrichment (Zhou
et al., 2013). This affinity matrix termed titanium (IV)-IMAC
(Ti4+-IMAC) was shown to possess high selectivity, sensitivity,
and quantification reproducibility, allowing in-depth monitoring
of more than 10,000 phosphorylation events by a single-step
phosphopeptide enrichment (de Graaf et al., 2014).
Predominantly, large-scale phosphoproteomics analyses are
based on peptides derived from the tryptic digestion of proteins
in a lysate (Mallick et al., 2007; Sharma et al., 2014). Trypsin
represents a valid choice because it is highly specific, very
effective and, compared to the other available proteases, gen-
erates a higher number of peptides in the preferred mass range
suitable for identification by MS (Guo et al., 2014; Swaney et al.,
2010). As a result, the vast majority of the reported workflows in
proteomics are dominated by using exclusively trypsin (Tsiat-
siani and Heck, 2015; Wilhelm et al., 2014). However, potentially
interesting sequences, and thus particular relevant phospho-
sites, will remain occluded by this approach, as the tryptic pep-
tides generated do not always possess appropriate physico-
chemical properties that make them suitable for detection by
LC-MS/MS.
Although it has been shown that proteome coverage can be
increased by using multiple alternative proteases (Bian et al.,
2012; Gauci et al., 2009; Guo et al., 2014; Peng et al., 2012; Swa-
ney et al., 2010), this approach has not systematically been
investigated for the analysis of PTMs. Here, we report a system-
atic study using five commercially available proteases to extend
the coverage of the phosphoproteome. We targeted the phos-
phoproteome of human Jurkat T cells stimulated by PGE2 and
used Ti4+-IMAC for the enrichment of the phosphopeptides
from lysates digested in parallel by AspN, chymotrypsin, GluC,
AB
Figure 1. Generation of the Human Phosphopeptide Atlas
(A) Jurkat T lymphocyte cells were stimulated for 10 min with PGE2, lysed, and
digested in parallel with one of the five proteases: AspN, chymotrypsin, GluC,
LysC, and trypsin. Each digest was divided over three Ti4+-IMAC phospho-
peptide enrichment columns, loading 200 mg per enrichment, resulting in 15
samples that were analyzed by nLC-MS/MS. The color scheme representing
the data on each individual protease is kept consistent throughout the
manuscript. These colors are AspN, orange; chymotrypsin, gray; GluC,
vermillion; LysC, sky blue; and trypsin, blue.
(B) Enrichment efficiency and total number of unique phosphosites detected.
The bar chart represents the median enrichment efficiency calculated as
the percentage of phosphopeptides in the six MS runs, demonstrating the
high selectivity (typically above 90%) of the Ti4+-IMAC enrichment for all
used proteases. For each population, the whiskers represent the minimum
and maximum selectivity. The number of unique phosphosites identified in
the data sets originating from each protease is reported underneath the
bars.LysC, and trypsin, starting with just 600 mg for each digest. Using
a stringently filtered cumulative data set of 37,771 unique phos-
phopeptides, linked to 18,430 unique phosphosites, we were
able to answer the following questions: is it beneficial to do
phosphoproteomics using multiple enzymes rather than extend-
ing the number of trypsin replicates? Do different proteases
possess unique phosphopeptides features? Is the enzymatic
efficiency affected by the presence of a phosphorylated site?
Is label-free quantitative phosphoproteomics possible when us-
ing other enzymes than trypsin? Is there at present a detectable
bias toward ‘‘tryptic’’ phosphosites in the very large public de-
positories? The final result of our work is a human phosphopep-
tide resource, made publicly available, that can be queried
by using a simple and intuitive web interface to facilitate the
identification of the most-suitable protease for both shotgun
as well as targeted MRM/PRM/SWATH-based phosphoproteo-
mics studies.CeRESULTS AND DISCUSSION
Generation of the Data for an Augmented Human
Phosphopeptide Atlas
All phosphoproteomics data presented here were obtained from
human Jurkat T cells that were harvested following 10 min of
PGE2 stimulation. PGE2 increases the levels of cAMP, thereby
activating among other the cAMP-dependent kinase PKA. We
did choose PGE2-activated T cells, as recently a rather large
trypsin-based phosphoproteomics data set was made available
for this system using a similar experimental approach (de Graaf
et al., 2014). The activated T cells were lysed and extracted pro-
teins were digested with each of the five enzymes, i.e., AspN,
chymotrypsin, GluC, LysC, and trypsin, using identical protocols
as described in detail earlier (Low et al., 2013). Three indepen-
dent Ti4+-IMAC enrichments were used for each of the five
digests to specifically enrich for phosphopeptides, and only
200 mg of digest material were used as input per enrichment
(Figure 1A). All 15 samples were analyzed in replicate by nLC-
MS/MS using 150-min gradients and a decision-tree-driven pep-
tide fragmentation scheme, selecting the appropriate activation
technique being either CID or ETD, depending on the precursor
charge state and m/z (Frese et al., 2011; Swaney et al., 2008).
In total, more than 1.1 3 106 MS/MS spectra were acquired
(Table 1), resulting in 37,771 unique phosphopeptides origi-
nating from 5,326 phosphoproteins. A complete list of all the
identified peptide to spectrum matches (PSMs), (phospho)pep-
tides, including confidence scores for identification and site
localization for each enzyme, can be found in Table S1 and
on the web-based resource page (http://phosphodb.hecklab.
com). Among the five data sets, trypsin comprised the largest
number of unique phosphopeptide identifications (13,476),
followed by GluC (7,502), LysC (6,595), AspN (6,407), and
chymotrypsin (5,376).
Comparison of Data Sets Originating from Different
Proteolytic Digests
As Ti4+-IMAC has been so far only used for the enrichment of
phosphopeptides from tryptic digests, we first assessed the
feasibility and validity of using this material for the enrichment
of non-tryptic digests. The data from three independent Ti4+-
IMAC enrichments clearly indicate a high selectivity (Figure 1B),
ranging from on average 86% for LysC up to 98% for GluC,
similar to the enrichment efficiency obtained for trypsin (90%).
Thus, the selectivity for enrichment by Ti4+-IMAC seems prote-
ase independent. We next examined the number of phosphory-
lation sites identified by each protease (Table 1; Figure 1B).
Using the same amount of sample (600 mg), we recovered
9,199 unique phosphorylation sites (from 13,476 unique phos-
phopeptides) in the tryptic digest; whereas, around 4,000 unique
phosphosites sites could be recovered from each of the other
digests. All these numbers are quite favorable (considering the
low amount of sample used) but also clearly show that trypsin
seemingly outperforms the other enzymes in number of identi-
fied sites. Such a lower efficiency for GluC, AspN, LysC, and
chymotrypsin is in agreement with what has been reported at
the unmodified peptide level (Low et al., 2013; Swaney et al.,
2010). However, we hypothesize that there may be multiplell Reports 11, 1834–1843, June 23, 2015 ª2015 The Authors 1835
Table 1. Unique Phosphopeptide and Phosphoprotein Identifications in Each of the Protease Data Sets
Protease Trypsin LysC AspN GluC Chymotrypsin Cumulative
No. MS/MS 248,753 224,227 204,657 208,559 225,911 1,112,107
No. PSMs 87,650 59,104 45,095 67,808 40,064 299,721
Success rate (%) 35.2 26.4 22.0 32.5 17.7 26.9
No. CIDs 64,970 24,523 19,438 28,714 22,270 159,915
No. ETDs 22,680 34,581 25,657 39,094 17,794 139,806
CID/ETD ratio 2.86 0.71 0.76 0.73 1.25 1.14
No. phosphopeptides 13,476 6,595 6,407 7,502 5,376 37,771
No. phosphoproteins 3,519 1,868 2,021 2,225 1,936 5,326
Although the number of MS/MS events and phosphopeptide enrichment efficiency are alike in all digests, the number of unique phosphopeptides
detected is twice as high for trypsin as for the other proteases. ETD is highly beneficial and complementary in the identification of phosphopeptides,
especially in the digest of LysC, AspN, and GluC.origins for this observation. At least part of the higher number of
identifications for trypsin can be attributed to the higher identifi-
cation rates (PSMs), likely due to a positive bias of search en-
gines toward trypsin (Granholm et al., 2014). In addition, superior
fragmentation of tryptic peptides, especially in CID/HCD, attri-
butes further to the higher number of identification for trypsin
(Meyer et al., 2014; Swaney et al., 2010). In line with this notion,
our data show that the use of ETD fragmentation complementary
to CID/HCD fragmentation is substantially more beneficial for
digests of LysC, AspN, and GluC and not so much for trypsin
(see Table 1).
Next, we evaluated the unique phosphorylation sites per pro-
tease data set and between the five data sets. To compare the
data sets, we applied stringent site assignments criteria by using
the phosphoRS algorithm (Taus et al., 2011), which allowed to
confidentially localize the phosphorylation event with amino
acid resolution. The resulting data set reveals that, by using
different proteases, we can significantly enhance our phospho-
peptide atlas, as the five data sets turned out to be extremely
complementary. As illustrated in Figure 2A, we cumulatively
identify 18,430 unique phosphosites, albeit that just about 27%
of these were identified in more than one protease data set
and only a marginal fraction of 0.3% (i.e., 61) could be identified
in all five data sets.
Characterization of the Identified Phosphopeptides
Reveals that Phosphorylation Induces Widespread
Protease Missed Cleavages
To gain more insight into the complementarity observed among
the five data sets, we first evaluated the global physico-chemical
characteristics of the phosphopeptides. First, we examined the
lengthdistributionof the identifiedphosphopeptides (FigureS1A),
which revealed that they possess on average similar length distri-
butions, with most of them having a length in between 14 and 25
amino acids. Not surprisingly, identified phosphopeptides gener-
ated by trypsin digestion are on average relatively shorter (7–20
amino acids long) compared to phosphopeptides identified after
GluC digestion, which generates longer sequences (14–30 amino
acids long). Although the results generally correlated with data
reported in other studies for unmodified peptides (Biringer et al.,
2006;Kalli andHa˚kansson,2010;Swaneyetal., 2010),wenoticed1836 Cell Reports 11, 1834–1843, June 23, 2015 ª2015 The Authorsthat there was a substantial shift in the observed average peptide
length for trypsin, from10 for unmodifiedpeptides to18amino
acids for phosphopeptides. This behavior has been attributed by
the presence of a phosphorylation site in close proximity to the
sites of proteolytic cleavage, which prevent trypsin and LysC
cleavage and neighboring sites (Molina et al., 2007). To explore
whether a similar phenomenon exists in the other protease data
sets, we investigated the frequency of missed cleavage events
in all five data sets. As depicted by the violin plots in Figure S1B,
relative high number of missed cleavages is present in the phos-
phopeptide data sets from each proteolytic digest. If the enzy-
matic digestions were inefficient, one would expect unmodified
peptides to show the samedistribution. On the contrary, the anal-
ysis on the unmodified peptides, co-purified by the Ti4+-IMAC
material, reveal a more efficient digestion, similar to the one
commonly observed for the same enzymes in large-scale prote-
ome studies (Low et al., 2013). Thus, the here-generated data
set reiterates that the number of missed cleavages is significantly
higher for phosphorylated peptides, not only in digest generated
by trypsin and LysC but also in AspN, GluC, and chymotrypsin
digests. To gain closer insights into the influence of phosphoryla-
tion on digestion, we probed the composition of the amino acid
sequence surrounding themissed cleavage site for the phospho-
peptides detected in each data set (Figure S1C). For each data
set, the residue corresponding to an uncleaved site was centered
and the distance to the nearest localized phosphoresidue, within
±5 positions, was calculated. If phosphorylation has no influence
on the cleavage, an even distribution of the phosphoresidue
should be observed around the missed cleaved bond. In accor-
dance with previous studies (Dickhut et al., 2014; Gershon,
2014), this analysis shows for trypsin and LysCa phosphoresidue
in the positions +1, +2, and +3 selectively hampers cleavage. For
AspNandGluC, phosphorylation impedes cleavagemostly when
located at position2,whereas for chymotrypsin, a phosphoryla-
tion at the +1 position hampers protease activity. The negative
correlationbetweencleavageefficiencyandnearbyphosphoryla-
tion events is thus generally protease independent, albeit that
specific protease-dependent rules govern the most-affecting
sites.
We also determined the charge distribution of the phospho-
peptides in each data set. As illustrated in Figure S1D, trypsin
AC
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Figure 2. Qualitative and Quantitative Benefit of Using Multiple Proteases in Phosphoproteomics
(A) Venn diagrams displaying the overlap in detected unique phosphosites between the data sets generated by trypsin, LysC, AspN, GluC, and chymotrypsin.
Nearly 3/4 of the phosphosites (i.e., 13,500) were not detected by more than one protease, indicative of the high orthogonality of the multi-protease strategy.
(B) Benchmarking the unique and distinct phosphorylation sites detected in each digest to the human phosphorylation sites reported in the comprehensive
PhosphoSitePlus database depository (153,900 entries) and the related large Jurkat (phospho)proteome data set reported earlier by de Graaf et al. (2014;
16,200 entries). The here-identified phosphopeptide sites in the AspN, GluC, and chymotrypsin digests are clearly underrepresented both in the public de-
pository as well as in the largest reported Jurkat cell (tryptic) phosphoproteome. These comparisons clearly reveal a substantial tryptic bias in public depositories.
(C) Heatmap, based on spectral count scores, illustrating the contribution of each protease in the detection of a particular phosphosite. Black color means not
detected. Phosphosites were further grouped using hierarchical clustering (distance metric was Euclidean correlation and linkage method was average).
(D) Domain structures for three representative phosphoproteins (RB1, STMN1, and NPM1), bearing multiple phosphosites, whereby by using bars is presented
how well they are detectable in the different digests. Black color means not detected. Residue numbers of the identified phosphorylation sites are indicated.digestion generates, predominantly, doubly and triply proton-
ated peptides. In contrast, LysC, AspN and GluC generated sub-
stantially more triply and higher charge state phosphopeptides.
Notably, even though the charge and length properties of theCechymotryptic peptides are very similar to the ones generated
by trypsin, the success rate in identification for chymotrypsin
was a factor 2 lower (Table 1). This can be partly explained by
the low specificity of chymotrypsin, which may cleave at fivell Reports 11, 1834–1843, June 23, 2015 ª2015 The Authors 1837
different amino acids, posing a bigger challenge to current
search engines. Despite this lower efficiency, the added value
of using chymotrypsin is illustrated by the 1,795 uniquely identi-
fied phosphosites (Figure 1A). We think this can be explained by
the rather unique capability of chymotrypsin to cleave peptide
bonds consisting of amino acids with hydrophobic (L and M)
and aromatic large side chains (F, W, and Y). Therefore, we
hypothesize that, by using chymotrypsin, more peptides from
hydrophobic protein regions can be retrieved, often missed in
tryptic digests.
Tryptic Bias in Public Phosphopeptide Depositories
We evaluated the here-identified 18,430 phosphorylation sites
against two very large public data depositories (Figure 2B). First,
we matched the phosphosites identified in the data sets of
each protease against one of the largest manually curated data-
base repositories: PhosphoSitePlus (Hornbeck et al., 2012;
153,900 human phosphorylation sites), which includes results
from large-scale phosphoproteomics experiments but also
from lower-throughput assays based on immune purification us-
ing phospho-specific antibodies, cumulating data from different
cellular and/or tissue origins. We observed that our multiple-pro-
tease-based data sets confidently identified 6,032 phosphoryla-
tion sites not yet reported in PhosphoSitePlus. Although our
trypsin data set yielded also a number of not yet reported sites,
more than 70% of the novel sites came from the data sets using
the other proteases.
Based on the fact that they have similar sizes, a more-fair
benchmark we hypothesized would be to compare the current
data sets to the recently (by us) reported exhaustive trypsin-
based phosphoproteomics data set acquired from the same
Jurkat T lymphocyte cells by using the same enrichment strat-
egy, albeit by using 54 distinctive Ti4+-IMAC-based enrich-
ments (16,200 phosphorylation sites; de Graaf et al., 2014).
In that earlier experiment, we likely approached the maximum
in detection of tryptic phosphosites by doing 54 replicates
across six time points, instead of the three used here. Strik-
ingly, this analysis (Figure 2B) revealed that many phosphosites
found by using the alternative proteases were not detected
earlier in the exhaustive trypsin-based experiments. In some
of these data sets, this accumulated to close to 2/3 of the
data set, i.e., AspN (59%), chymotrypsin (57%), and GluC
(62%). From these data, we conclude that, although trypsin
performs very well, it provides a biased representation of the
phosphoproteome. This bias can be substantially reduced,
making use of the orthogonality of the alternative proteases
applied here.
Quantitative Assessment of Protease Bias for Individual
Phosphoproteins: Impact on Studying Cellular Signaling
In absence of any protease bias, the five proteases should
equally contribute to the detection of a particular phosphosite
on a given protein, especially for the 3,300 phosphosites for
which high numbers of spectra (R10) were successfully and
unambiguously matched to a peptide sequence. However,
when we evaluated each protease contribution by using a spec-
tral count score (see Data Analysis section), we observed
massive differences (Figures 2C and S2). Many phosphosites1838 Cell Reports 11, 1834–1843, June 23, 2015 ª2015 The Authorswere either highly overrepresented or underrepresented in par-
ticular protease data sets. Consequently, certain protein phos-
phorylation events are considerably better detectable by using
one or two proteases over the others. To further illustrate this
phenomenon, we focused on a group of key signaling phospho-
proteins, e.g., a list of reported well-known oncogenes (Table
S2). In signal transduction, reversible protein phosphorylation
often represents an activating or deactivating switch for protein
activity, which can play an important role in the pathogenesis
of human cancers (Chong et al., 2008). Therefore, the identifica-
tion and characterization of the phosphorylation events associ-
ated to oncogenic signaling are particularly important. Our
data clearly show that, even though trypsin is an efficient and
robust protease that generates the highest number of (phos-
pho)peptides detectable by MS experiments, it may not always
be the optimal choice for specific important regulatory sites.
We further zoom in on three illustrative examples from the full
list of proteins given in Figure S2, namely, the retinoblastoma
protein (RB1), stathmin (STMN1), and nucleophosmin (NPM1)
(Figures 2D and S3). Complementary, the web-based database
set up to make our data publicly available (http://phosphodb.
hecklab.com) provides similar analysis on all the here-reported
phosphoproteins.
The retinoblastoma protein is an important tumor suppres-
sor protein that is dysfunctional in several major cancers (Mur-
phree and Benedict, 1984). The hypo-phosphorylated form
interacts with and sequesters the E2F1 transcription factor,
leading to cell cycle arrest. On the contrary, the hyper-phos-
phorylated form is unable to interact with E2F1 and, therefore,
unable to restrict progression from the G1 to the S phase of
the cell cycle. The main regulators of RB1 activity are several
members of the cyclin-dependent kinases (CDKs) family,
which can phosphorylate RB1 at several different sites, such
as S249, S252, S807, S811, T821, and T826 (Knudsen and
Wang, 1997). Evidently, in ideal phosphoproteomics experi-
ments, all these sites should be monitored. For three of these
sites, our data clearly reveal that chymotrypsin is the protease
that would substantially facilitate their detection by MS (Fig-
ures 2D and S3).
Another example is provided by STMN1, a protein involved in
the biogenesis and remodeling of the cellular microtubule cyto-
skeleton. STMN1 activity depends on phosphorylation of at least
four key serine residues (S16, S25, S38, and S63) by different
kinases (Santamarı´a et al., 2009). Our data show that, whereas
S16, S25, and S38 could be detected by each protease, S63
clearly possesses a strong preference in detection by using
AspN. This suggests that S63 would be underrepresented in
conventional tryptic-based phosphoproteomics approaches.
Indeed, when we evaluated these four sites in the PhosphoSite-
Plus database, we discovered that S16, S25, and S38 were
detected by over 100 large-scale mass-spectrometry-based ex-
periments, whereas S63 has been reported in just 50 data sets.
Moreover, in the latter case, these observations originated
mainly from experiments in which a targeted low-throughput
approach had been used, i.e., by using motif-specific antibodies
directed against kinase motifs (e.g., PKA, PKC, and PKD). Also,
STMN1 S31 phosphorylation was readily detected with over
hundreds of PSMs in the chymotrypsin and AspN data sets,
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Figure 3. Distribution of the Sequence Motifs Extracted from the
Protease-Linked Phosphorylation Data Sets
The motif-x algorithm revealed more than 130 unique phosphorylation motifs
in the phosphopeptides data sets. They could generally be classified into
proline-directed, basophilic, and acidophilic motifs (http://www.hprd.org). The
contribution of each class of motifs is given, and the total number of phos-
phosites that could be assigned to these motifs is shown in brackets. Most
notably, whereas for trypsin, AspN, and chymotrypsin the ratio between
acidophilic and basophilic motifs is close to 1:1, GluC and LysC show a clear
bias toward the acidophilic and the basophilic motifs, respectively. Addition-
ally, compared to the other proteases, chymotrypsin seems to be biased
toward proline-directed motifs.but only six PSMs were detected in the much-larger tryptic data
set. Validating our trypsin bias hypothesis, this site turned out to
be also underrepresented in PhosphoSitePlus.
As third example, we highlight nucleophosmin. NPM1 is
overexpressed, mutated, and chromosomally translocated in
many tumor types (Falini et al., 2007). During the different
phases of the cell cycle NPM1 can be phosphorylated at mul-
tiple sites by PLK or CDK kinases, modifications that have been
proposed to trigger or abolish NMP1 functions. In our data, we
detect a high number of PSMs for S4, S10, S70, S125, T234,
T237, and S242 and lower levels of PSMs for S260, S227,
S293, S243, and S254 (Table S2). However, of these S10,
T234, T237, and S242 are hardly detectable in the tryptic
data set, whereas these sites have high numbers of PSMs in
the AspN and chymotrypsin data sets (Figures 2D and S3).
GluC digestion seems to be really beneficial for T234 and
T237, whereas S70 is only detected with high PSMs in the
data from the tryptic and chymotryptic digests. In summary,
our data on nucleophosmin reveal that each site in this protein
has a preference in detectability correlated with different prote-
ases (Figure S3). Moreover, only by using all five proteases, we
are able to map all known important regulatory phosphosites in
this protein.
These three proteins illustrate the protease complementarity,
which holds true for all the other phosphoproteins detected
and listed in Table S2. Clearly, when the phosphorylation status
of a given protein needs to bemonitored, the use of complemen-
tary proteases is highly beneficial. Therefore, targeted prote-
omics studies should be expanded to include non-tryptic pep-
tides, as intensities likely increase by factors between 10 and
10,000.
Presently, a number of factors limit the usefulness of these
non-tryptic phosphopeptides for systems biology studies. First,Cethe public available repositories are nearly exclusively based
on tryptic peptides, underrepresenting many potential inter-
esting sites. Second, spectra are not always accessible to
assess the quality of phosphopeptide identification and the
accuracy of the phosphorylation site assignment. Moreover,
the data are mostly presented as lists of phosphosites,
whereas information at the phosphopeptide level might provide
more useful information for further analysis such as targeted
MRM/PRM/SWATH. To enhance the utility of our augmented
phosphopeptide atlas, we provide our data as a searchable
resource for targeted phosphoproteomics experiments (http://
phosphodb.hecklab.com). The users can browse through the
phosphorylation sites on their proteins of interest, apply
custom filters, visually identify which protease would be the
most suitable for the detection of the sites of interest, and
export the necessary parameters to setting up the MRM/
PRM-like assays.
Our resource provides a first draft of a less-biased human
phosphopeptide atlas that may be further expanded by import-
ing data from other proteases, other cell lines, and tissue. More-
over, we believe that this resource, which also includes all
raw data and MS/MS spectra interpretations, may help bio-
informaticians in their efforts to develop and improve computa-
tional prediction and analysis tools for non-tryptic peptides in
phosphoproteomics analysis, which we here identified as being
one of the current likely bottlenecks.Computational Analysis on the Identified
Phosphorylation Sites
To assess a potential preference for certain kinase motifs in
the five phosphopeptides data sets, we subjected the here-
identified phosphorylation sites first to the motif-x algorithm
(Schwartz and Gygi, 2005). A total of 132 distinct motifs could
be defined among all the five proteases data sets (Table S3).
By convention, we could classify these kinase motifs into
four well-defined groups: acidic, basophilic, proline-directed,
and ‘‘other’’ motifs (Figure 3). This analysis revealed that
the sequences bearing the [pS/pT]P motif, target of the very
large family of proline-directed kinases including, among
others, CDKs and MAPKs (Lu et al., 2002), were almost evenly
spread across all the five proteases data sets, with just AspN
and chymotrypsin possibly displaying a slight overrepresenta-
tion. Considering next the substrates of basophilic and acido-
philic kinases, a clear bias is observed in between the data
sets, with especially LysC and GluC being specific outliers
(Figure 3).
Motifs in the basophilic group convolute around the PKA/Akt/
PKC [R/K]X[R/K]XX[pS/pT] consensus motif (Pearce et al.,
2010). Many of the arginine-containing sequences were
retrieved from the tryptic digests, whereas lysine-rich motifs
were mainly present in the LysC data set, making these two
proteases the most suitable when the interest lays in the
analysis of basophilic kinases substrates. Likewise, we hypoth-
esized that AspN and GluC would be the protease of choice in
detecting substrates of acidophilic kinases (e.g., CK1, CK2,
and PLKs), which mostly target serine and threonine residues
flanked by acidic residues (Amanchy et al., 2007). Our analysisll Reports 11, 1834–1843, June 23, 2015 ª2015 The Authors 1839
revealed that only GluC showed a clear bias toward detecting
peptides bearing an acidophilic motif.
All the identified phosphorylation sites were further subjected
to the NetworKIN algorithm (Horn et al., 2014) to predict the
kinases involved (Table S3). This analysis predicted that phos-
phorylation of the acidophilic motifs was mostly associated to
the kinases CK1, CK2, and SGK1. These three kinases were
mainly overrepresented in the trypsin data set. In agreement
with above basophilic kinases, members of the AGC and
CAMK groups were predominantly enriched in the trypsin and
LysC data sets. Interestingly, the NetworKIN analysis also re-
vealed a bias toward LysC for almost all members of the GRK
family (Figure S4). GRKs are activated downstream of GPCRs,
which we here activated by PGE2, and function to phosphorylate
and control the activity of these receptors. Unlike most AGC
kinases, for GRKs phosphorylation, the consensus motifs are
not clearly defined yet. It has been reported that some mem-
bers prefer acidic residues flanking the phospho-acceptor sites
whereas other members favor basic residues (Pitcher et al.,
1998). Indeed, a closer inspection of the phosphosites detected
in our data sets confirmed this binary characteristic, with lysine,
glutamic acid, or both residues in close proximity to the phos-
phorylated serine/threonine.
A Protease Bias in Label-free Quantification of
Phosphorylation Sites
Due to their highly dynamic spatial regulation, it is crucial
to perform quantitative studies on protein phosphorylation to
fully understand the signaling networks controlling cellular
fate. Many different strategies have been developed to accom-
plish this task (Macek et al., 2009). Recently, others and we
demonstrated the possibility of performing in-depth and high-
throughput reproducible label-free phosphoproteome quantifi-
cation (Courcelles et al., 2013; de Graaf et al., 2014; Montoya
et al., 2011; Soderblom et al., 2011). Here, we assessed the
feasibility of obtaining similar quantitative data when proteases
other than trypsin are used, making it possible to profile phos-
phosites that would be easily missed in a conventional trypsin-
based workflow. Such an analysis would provide insight into
the reproducibility of the enrichment protocol but also the repro-
ducibility in digestion by the different proteases. To minimize
any potential bias of the different algorithms used to perform
identification and quantification, we processed the here-ob-
tained data through the same computational pipeline as previ-
ously described (de Graaf et al., 2014).
The data from three independent enrichments within each
of the distinct protease data sets show a high quantitative
reproducibility across all phosphosites, with a correlation typi-
cally around 0.85 (Figures 4A and S5). Therefore, we conclude
that quantitative phosphoproteomics, including label-free
quantification, is possible, not only by using trypsin, as shown
before (de Graaf et al., 2014; Montoya et al., 2011), but also by
using any of the other four alternative proteases used here.
However, when we compare data generated by using more
than one protease, the correlation is low (r 0.25–0.55). These
lower correlations further endorse the previously demonstrated
substantial protease bias in data sets generated in yeast on
non-modified peptides (Peng et al., 2012). In Figure 4B, a1840 Cell Reports 11, 1834–1843, June 23, 2015 ª2015 The Authorszoom in of some of these correlation plots is given, highlighting
a few illustrative phosphosites in which one protease clearly
outperforms the other, resulting sometimes in a more than
1,000-fold higher phospho-site bearing peptide intensity. As
an example, S37 on RB1 is easily detected as a high abundant
peptide following trypsin digestion. In the GluC digest, its
intensity is much lower, affecting the accuracy of the peak
detection. Similarly, the tryptic peptide bearing S10 on NPM1
is low abundant, whereas the AspN peptide bearing this S10
site is about 4-fold more intense. We believe that these results
support the observation that the best peptides are not neces-
sarily tryptic (Peng et al., 2012), highlighting the valuable
contribution of non-tryptic peptides also in quantitative phos-
phoproteomics analysis.
To further demonstrate that some phosphorylation sites can
be hardly observable in tryptic digests, we conducted a tar-
geted proteomics experiment making use of a well-defined in-
clusion list (Jaffe et al., 2008; Schmidt et al., 2008). With this
approach, the mass spectrometer is specifically instructed to
sequence only pre-selected ion species, overcoming the sto-
chastic undersampling that may occur during LC-MS/MS anal-
ysis. As a proof of principle, we selected two phosphorylation
sites with a well-known biological significance, S780 on RB1,
which is one of the residues modulating the activity of RB1 dur-
ing the cell cycle, and T638 on PRKCA, one of three residues
needed to be phosphorylated for full activation of this kinase.
We hypothesized that the two phosphosites would be easier
to assay using chymotrypsin and AspN, respectively, rather
than trypsin because of the observed differences in spectral
count values for the candidate phosphopeptides. Equal starting
amounts of Jurkat cells lysate were digested using AspN (five
replicates), chymotrypsin (five replicates), or trypsin (seven rep-
licates). Each digest was subjected to phosphopeptide enrich-
ment as described above, and resulting phosphopeptides were
then analyzed by using the inclusion-list-based approach. As
depicted in Figure 4C, a difference in peak area of 200-fold
was observed for S780 on RB1. Alike for T638 on PRKCA,
the use of AspN led to an 20-fold more-intense phospho-
site-bearing peptide when compared to its tryptic counterpart.
To demonstrate that this difference is not caused by different
amount of sample loaded on the column during the nLC-MS/
MS analysis, we compared the total ion current (TIC) of all
the inclusion-list-based acquisitions (Figure S6). This analysis
revealed that similar intensity of the TICs was measured across
the different digests, demonstrating that equal amounts were
loaded of the phosphopeptides. We conclude thus that the
biases revealed by our spectral-counting-based methods are
also detectable and present when adopting a targeted prote-
omics approach.
Conclusions
Although high-throughput phosphoproteomics approaches can
nowadays identify several thousands of unique phosphosites,
it has become apparent that a large portion of regulatory impor-
tant phosphorylation events remain elusive. These issues are
partly due to the fact that many sites are simply inaccessible or
very hard to detect following digestion with trypsin, hampering
MS-based studies. In this work, we demonstrated that the use
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Figure 4. Label-free and Targeted Phos-
phoproteomics Using Complementary Pro-
teases
(A) Pearson correlation matrix of all performed
experiments reveal a high correlation in phos-
phosite intensity when data sets are obtained
following digestion by the same protease (dashed
squares; r > 0.8) but a low correlation between
data sets originating from different proteases
(r 0.25–0.55).
(B) Illustrative scatter plots depicting phosphosite-
bearing peptide intensities (log base 2) in digests
obtained by different proteases. The plots are
extracted from Figure S5. Two phosphosites are
highlighted in red, showing a clear bias in intensity
toward detection by trypsin (RB1-S37) or chymo-
trypsin (NPM1-S10) in this label-free intensity-
based analysis.
(C) Also, a targeted phosphoproteomics experi-
ments on specific phosphorylation sites shows a
clear bias in average precursor intensity (error
bars, ±SD) toward detection by chymotrypsin
(RB1-S608) and AspN (PRKCA-T638).of multiple proteases is beneficial for large-scale phosphopro-
teomics analysis, exposing many regulatory relevant phospho-
sites on key signaling proteins, which would be occluded when
only using trypsin. Notably, we also substantially increased theCell Reports 11, 1834–184phosphoproteome coverage, ultimately
showing that this workflow enables
reproducible, quantitative, and comple-
mentary phosphoproteomic analysis. As
a result, we make publicly available a hu-
man phosphopeptide atlas of more than
37,771 unique phosphopeptides, corre-
lating to over 18,000 unique phospho-
sites. Researchers interested in particular
phosphorylation events on targeted pro-
teins may use the here-described web
tool to pick the appropriate protease
that will lead to successful detection of
their sites of interest and extract the
necessary parameters to construct tar-
geted assays for phosphoproteomics
studies.
Our extensive resource also allows us
to conclude several important technical
issues, notably, (1) Ti4+-IMAC phospho-
peptide enrichment is equally efficient
and selective independent of the prote-
ase used; (2) cumulative evidence from
all protease data sets demonstrates
unambiguously that protein phosphoryla-
tion reduces the cleavage efficiency near
those sites for each protease used; (3)
label-free quantitative phosphoproteo-
mics is possible, however, only when
comparing data generated by one prote-
ase; and (4) there is a clear bias towardtrypsin in the currently available and widely used phosphopep-
tide and phosphosite databases.
We expect our data will be a valuable resource for researcher in
the signaling and proteomics field and may assist in encouraging3, June 23, 2015 ª2015 The Authors 1841
people to perform, next to trypsin-based experiments, additional
experiments with one or more complementary proteases.
EXPERIMENTAL PROCEDURES
Sample Preparation and MS Analysis
Jurkat T lymphoma cells were resuspended at a final concentration of 1 or
2 3 106 cells/ml with 10 mM PGE2 in RPMI and incubated for 10 min. After
treatment, Jurkat cells were lysed in 50 mM ammonium bicarbonate (pH
8.0), 8 M urea, 1 mM sodium orthovanadate, complete EDTA-free protease
inhibitor mixture, and phosSTOP phosphatase inhibitor mixture (both
Roche) lysis buffer. Digested proteins were subjected to phosphopeptide
enrichment using Ti4+-IMAC beads (Zhou et al., 2013), and enriched phos-
phopeptides were identified on a LTQ-Orbitrap Elite (Thermo Scientific) or
Orbitrap Fusion (Thermo Scientific) using a decision-tree-based ion trap
CID or ETD fragmentation. Further details are given in the Supplemental
Experimental Procedures.
Data Analysis
The MS data were processed using Proteome Discoverer 1.4 (Thermo Scien-
tific) and searched with the MS-GF+ search tool (Kim and Pevzner, 2014; Kim
et al., 2010) against a SwissprotHomo sapiens database. The phosphorylation
site localization of the identified phosphopeptides was performed using the
phosphoRS algorithm 3.1 (Taus et al., 2011). For label-free analysis, raw
data were processed with MaxQuant version 1.3.0.5 (Cox and Mann, 2008).
For inclusion-list-based experiments, the data analysis was done manually.
Extracted ion chromatograms (XICs) for a given parent mass were extracted
with Xcalibur 3.0.63 (Thermo Scientific) with a mass tolerance of ±20 ppm.
To evaluate the detectability of a given phosphopeptide, we made use of a
spectral counting score (SCS) (Old et al., 2005; Zhang et al., 2006). The SCS
for a given phosphorylation site was calculated as follows: (1) the amount of
PSMs of that phosphosite in a given protease data set was divided by the total
spectral counts obtained by that protease and then (2) the obtained value was
normalized to 100% on the sum of the five values obtained from each prote-
ase. Further details are given in the Supplemental Experimental Procedures.
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